Details for New Drug Application (NDA): 021807
✉ Email this page to a colleague
The generic ingredient in SOLTAMOX is tamoxifen citrate. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
Summary for 021807
Tradename: | SOLTAMOX |
Applicant: | Mayne Pharma Commrcl |
Ingredient: | tamoxifen citrate |
Patents: | 0 |
Pharmacology for NDA: 021807
Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 021807
Suppliers and Packaging for NDA: 021807
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SOLTAMOX | tamoxifen citrate | SOLUTION;ORAL | 021807 | NDA | Mayne Pharma | 51862-682 | 51862-682-00 | 1 CONTAINER in 1 CARTON (51862-682-00) / 150 mL in 1 CONTAINER |
SOLTAMOX | tamoxifen citrate | SOLUTION;ORAL | 021807 | NDA | Mayne Pharma | 51862-682 | 51862-682-01 | 1 CONTAINER in 1 CARTON (51862-682-01) / 150 mL in 1 CONTAINER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | EQ 20MG BASE/10ML | ||||
Approval Date: | Oct 29, 2005 | TE: | RLD: | Yes |
Expired US Patents for NDA 021807
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mayne Pharma Commrcl | SOLTAMOX | tamoxifen citrate | SOLUTION;ORAL | 021807-001 | Oct 29, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription